Tooba Rehman: Extending Impella 5.5 Support Beyond 14 Days in Cardiogenic Shock
Tooba Rehman, Medical Doctor, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Delighted to share my latest publication:
Impact of Impella 5.5 Duration Support and Clinical Outcomes in Cardiogenic Shock: A Systematic Review and Meta-Analysis
Cardiogenic shock remains one of the most challenging conditions we manage, and optimizing mechanical circulatory support strategies is critical.
In our latest meta-analysis (1,440 patients across 5 studies), we explored whether extending Impella 5.5 support beyond 14 days offers meaningful clinical benefits.
Grateful to my Amazing Team!”
Title: Impact of Impella 5.5 Duration Support and Clinical Outcomes in Cardiogenic Shock: Evidence from a Systematic Review and Meta-Analysis of Observational Studies
Authors: Mrunalini Dandamudi, Srinivas Vunnamb, Tooba Rehman, Muhammad Aqib Faizan, Miguel A Samaniego-Laguna, John Cedric Mojica, Juliana Giorgi
Read the Full Article on JHTL OPEN
Muhammad Aqib Faizan, Clinical Intern at District Headquarter Hospital, MTI, DIKhan, shared this post, adding:
“Significantly higher risk of implant-site hematoma and infection necessitates meticulous vascular management, infection-prevention strategies and close clinical surveillance.”
Stay updated with Hemostasis Today.
-
Mar 26, 2026, 17:33Melissa Bouchard: Navigating Prosthetic Valves and Anticoagulation in Pregnancy at ACHD Hive Talks
-
Mar 26, 2026, 17:25Yonah S. Tehrani: Providing Clarity for Anticoagulant Selection in Acute Venous Thromboembolism
-
Mar 26, 2026, 17:18Casey Laycock: Spotlight on Community Champion – Jon Schneider of Spire
-
Mar 26, 2026, 17:16Rebecca Mellema: Journal Club Spotlight on Layilin and Platelet Hyperactivation in Inflammatory Bowel Disease
-
Mar 26, 2026, 17:15Shalom Zwiebel: Clinical Practice Evaluating PRP Systems and Supply Partners
-
Mar 26, 2026, 17:14Olivia C.: Pfizer’s mRNA BNT162b2 Vaccine Does Not Induce High Levels of Inflammation
-
Mar 26, 2026, 17:03Tilden Sokoloff: PRP Injections Enhance Sexual Function in Premenopausal Women
-
Mar 26, 2026, 17:02Mahesan Subramaniam: Japan Brings Mitochondrial Therapy to the Frontline of Cardiology
-
Mar 26, 2026, 17:01Kanishk Kumar: Discovering The Newest Advances in Hypercholesterolemia Research